name: Meniere's Disease
category: Complex
disease_term:
  preferred_term: Meniere disease
  term:
    id: MONDO:0007972
    label: Meniere disease
parents:
  - Inner Ear Diseases
  - Vestibular Disorders
pathophysiology:
  - name: Endolymphatic Hydrops
    description: >
      Meniere's disease is characterized by distension of the endolymphatic space
      (endolymphatic hydrops) due to impaired reabsorption of endolymph or excess
      production. This results in rupture of the membranous labyrinth and mixing
      of endolymph and perilymph, leading to vestibular and cochlear dysfunction.
    evidence:
      - reference: PMID:27083887
        supports: SUPPORT
        snippet: "Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of MeniÃ¨re's disease."
        explanation: "This review confirms endolymphatic hydrops as the pathologic correlate of Meniere's disease."
  - name: Ion Transport Dysfunction
    description: >
      Abnormal regulation of fluid and ion homeostasis in the inner ear, particularly
      involving potassium transport in the stria vascularis and endolymphatic sac,
      contributes to endolymph accumulation and hydrops formation.
    biological_processes:
      - preferred_term: potassium ion transport
        term:
          id: GO:0006813
          label: potassium ion transport
  - name: Autoimmune and Inflammatory Mechanisms
    description: >
      Elevated inflammatory markers and autoantibodies have been found in some patients,
      suggesting that immune-mediated inner ear damage may contribute to disease
      pathogenesis in a subset of cases.
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
phenotypes:
  - name: Episodic Vertigo
    description: >
      Recurrent attacks of spinning vertigo lasting 20 minutes to several hours,
      often accompanied by nausea and vomiting. Episodes are unpredictable and
      can be severely debilitating.
    phenotype_term:
      preferred_term: paroxysmal vertigo
      term:
        id: HP:0010532
        label: Paroxysmal vertigo
  - name: Sensorineural Hearing Loss
    description: >
      Fluctuating, progressive hearing loss initially affecting low frequencies,
      eventually becoming permanent and affecting all frequencies as the disease
      progresses.
    phenotype_term:
      preferred_term: low-frequency sensorineural hearing impairment
      term:
        id: HP:0008573
        label: Low-frequency sensorineural hearing impairment
  - name: Tinnitus
    description: >
      Ringing, buzzing, or roaring sounds in the affected ear, often low-pitched
      and fluctuating. May become constant with disease progression.
    phenotype_term:
      preferred_term: tinnitus
      term:
        id: HP:0000360
        label: Tinnitus
  - name: Aural Fullness
    description: >
      Sensation of pressure or fullness in the affected ear, often preceding
      or accompanying vertiginous episodes.
    phenotype_term:
      preferred_term: aural fullness
      term:
        id: HP:0031704
        label: Abnormal ear physiology
  - name: Nausea and Vomiting
    description: >
      Autonomic symptoms accompanying acute vertigo episodes due to vestibular
      system dysfunction.
    phenotype_term:
      preferred_term: nausea and vomiting
      term:
        id: HP:0002017
        label: Nausea and vomiting
treatments:
  - name: Low-Sodium Diet
    description: >
      Dietary sodium restriction to reduce fluid retention and minimize
      endolymphatic hydrops. Often combined with diuretics.
    treatment_term:
      preferred_term: dietary intervention
      term:
        id: MAXO:0000088
        label: dietary intervention
  - name: Diuretic Therapy
    description: >
      Thiazide diuretics or acetazolamide to reduce endolymph volume and
      pressure, decreasing the frequency of vertigo attacks.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Betahistine
    description: >
      Histamine analog that improves inner ear blood flow and reduces
      vestibular symptoms. Widely used outside North America.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Intratympanic Injections
    description: >
      Injection of corticosteroids or gentamicin through the tympanic membrane
      to reduce vertigo. Gentamicin causes controlled vestibular ablation.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Vestibular Rehabilitation
    description: >
      Physical therapy exercises to improve balance and reduce dizziness by
      promoting central compensation for vestibular dysfunction.
    treatment_term:
      preferred_term: physical therapy
      term:
        id: MAXO:0000011
        label: physical therapy
  - name: Endolymphatic Sac Surgery
    description: >
      Surgical decompression of the endolymphatic sac to improve endolymph
      drainage and reduce hydrops, though efficacy is debated.
    treatment_term:
      preferred_term: surgical procedure
      term:
        id: MAXO:0000004
        label: surgical procedure
datasets:
